> top > docs > PMC:7787218 > spans > 1212-3211 > annotations

PMC:7787218 / 1212-3211 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T8 336-347 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T9 952-963 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T10 1121-1132 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T11 1293-1304 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T12 1548-1559 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T13 1722-1733 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T14 1831-1842 Phenotype denotes anaphylaxis http://purl.obolibrary.org/obo/HP_0100845
T15 1946-1953 Phenotype denotes allergy http://purl.obolibrary.org/obo/HP_0012393

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
40 355-360 Species denotes women Tax:9606
41 893-905 Species denotes participants Tax:9606
42 1332-1342 Species denotes SARS-CoV-2 Tax:2697049
43 458-469 Chemical denotes epinephrine MESH:D004837
44 1987-1998 Chemical denotes epinephrine MESH:D004837
45 409-423 Disease denotes drug allergies MESH:D004342
46 774-783 Disease denotes allergies MESH:D004342
47 1946-1953 Disease denotes allergy MESH:D004342

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T5 0-162 Sentence denotes The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom was the first to authorize emergency use of the Pfizer–BioNTech mRNA vaccine.
T6 163-470 Sentence denotes On December 8, 2020, within 24 hours after the start of the U.K. mass vaccination program for health care workers and elderly adults, the program reported probable cases of anaphylaxis in two women, 40 and 49 years of age, who had known food and drug allergies and were carrying auto-injectable epinephrine.
T7 471-690 Sentence denotes On December 11, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the Pfizer–BioNTech mRNA vaccine, and general vaccination of health care workers was started on Monday, December 14.
T8 691-888 Sentence denotes On December 15, a 32-year-old female health care worker in Alaska who had no known allergies presented with an anaphylactic reaction within 10 minutes after receiving the first dose of the vaccine.
T9 889-1591 Sentence denotes The participants who had these initial three reported cases of anaphylaxis would not have been excluded on the basis of their histories from the mRNA vaccine clinical trials.1,2 Since the index case in Alaska, several more cases of anaphylaxis associated with the Pfizer mRNA vaccine have been reported in the United States after vaccination of almost 2 million health care workers, and the incidence of anaphylaxis associated with the Pfizer SARS-CoV-2 mRNA vaccine appears to be approximately 10 times as high as the incidence reported with all previous vaccines, at approximately 1 in 100,000, as compared 1 in 1,000,000, the known and stable incidence of anaphylaxis associated with other vaccines.
T10 1592-1999 Sentence denotes The EUA for the Moderna mRNA vaccine was issued on December 18, and it is currently too soon to know whether a similar signal for anaphylaxis will be associated with that vaccine; however, at this time a small number of potential cases of anaphylaxis have been reported, including one case on December 24 in Boston in a health care worker with shellfish allergy who was carrying auto-injectable epinephrine.